About this policy
The comment period for the MolDX: EndoPredict Breast Cancer Gene Expression Test Local Coverage Determination (LCD) began on 06/21/17 and ended on 08/06/17. The notice period will begin on 1/18/2018 and will end on 03/05/18. The LCD will become effective on 03/06/2018. The following comments were received from the provider community:
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.